BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6870446)

  • 1. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R; Slaughter D
    Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
    D'Elia JA; Aslani M; Schermer S; Cloud L; Bothe A; Dzik W
    Ren Fail; 1987; 10(2):107-13. PubMed ID: 3120247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
    Verwey J; Boven E; van der Meulen J; Pinedo HM
    Cancer; 1984 Dec; 54(12):2878-81. PubMed ID: 6437662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
    Kikuchi H; Kanamaru R
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
    Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    Murgo AJ
    Am J Kidney Dis; 1987 Mar; 9(3):241. PubMed ID: 3826074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.